Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial

NCT06832644 is registered in ClinicalTrials.gov with IRCCS Policlinico S. Donato as lead sponsor.

NCT NCT06832644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06832644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Risk Prediction Approaches for the Primary Prevention of Cardiovascular Diseases in Italy: the CVRISK-IT Trial
Lead sponsor
IRCCS Policlinico S. Donato
Phase
Not applicable
Overall status
Recruiting
Start date
January 22, 2025
Completion date
January 1, 2030
Enrollment
30,000 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk, genetic cardiovascular risk